Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scandinavian Journal of Urology · 20.12.2023 · 58 · 133-140
DOI: 10.2340/sju.v58.14730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Urology, online erschienen am 20.12.2023. Verfasst von Mona Otrebski Nilsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Registry of Norway, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. moni@kreftregisteret.no. Hauptthemen laut MEDLINE: Decision Making, Shared, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
In comparable men with non-metastatic prostate cancer, radical prostatectomy (RP), radiotherapy (RAD) and active surveillance (AS) are treatment options with similar survival rates, but different side-effects. Healthcare professionals consider pretreatment shared decision making (SDM) to be an essential part of medical care, though the patients’ view about SDM is less known. In this article, we explore prostate cancer (PCa) patients’ SDM wish (SDMwish), and experiences (SDMexp). Material and methods: This is a registry-based survey performed by the Cancer Registry of Norway (2017–2019). One year after diagnosis, 5,063 curatively treated PCa patients responded to questions about their pre-treatment wish and experience regarding SDM. Multivariable analyses identified factors associated with SDM. Statistical significance level: p < 0.05.
Results
Overall, 78% of the patients wished to be involved in SDM and 83% of these had experienced SDM. SDMwish and SDMexp was significantly associated with decreasing age, increasing education, and living with a partner. Compared with the RP group, the probability of SDMwish and SDMexp was reduced by about 40% in the RAD and the AS groups.
Conclusion
Three of four curatively treated PCa wanted to participate in SDM, and this wish was met in four of five men. Younger PCa patients with higher education in a relationship, and opting for RP, wanted an active role in SDM, and experienced being involved. Effective SDM requires the responsible physicians’ attention to the individual patients’ characteristics and needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Registry of Norway, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. moni@kreftregisteret.no.
- Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Urology, Akershus University Hospital, Lørenskog, Norway.
- Cancer Registry of Norway, Oslo, Norway; Department of Research, Møre and Romsdal Hospital Trust, Ålesund, Norway.
- Cancer Registry of Norway, Oslo, Norway.
- Cancer Registry of Norway, Oslo, Norway; Department of Urology Vestfold Hospital Trust, Tønsberg, Norway; Institute of Cancer Genomics and Informatics Oslo University Hospital, Oslo, Norway.
- National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
Zitieren
APA
Otrebski Nilsson, M., Aas, K., Myklebust, T. Å., Gjelsvik, Y. M., Haug, E. S., Fosså, S. D., & Johannesen, T. B. (2023). Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?. Scandinavian Journal of Urology, 58, 133-140. https://doi.org/10.2340/sju.v58.14730
Vancouver
Otrebski Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Haug ES, Fosså SD, et al. Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?. Scandinavian Journal of Urology. 2023;58:133-140. doi:10.2340/sju.v58.14730
BibTeX
@article{OtrebskiNilsson2023,
author = {Otrebski Nilsson, Mona and Aas, Kirsti and Myklebust, Tor Å and Gjelsvik, Ylva Maria and Haug, Erik Skaaheim and Fosså, Sophie D and Johannesen, Tom Børge},
title = {Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?},
journal = {Scandinavian Journal of Urology},
year = {2023},
volume = {58},
pages = {133--140},
doi = {10.2340/sju.v58.14730}
}
EUVIMED